3 min read FDA Moves to End Compounded Semaglutide and Tirzepatide What It Means for Weight Loss Patients The FDA Just Proposed a Major Change to Compounded Weight Loss Drugs If you've been following the news about weight loss medications, you may have heard that the FDA announced a significant regulatory change on April 30, 2026
The compounded medications are prepared by a U.S.-licensed pharmacy
The Pharmaceutical Research and Manufacturers of America (PhRMA) also weighed in Hims & Hers newly announced Wegovy pill
Gradual dose titration of GLP-1 therapies can also improve tolerability, typically involving dose escalation every 4 weeks or longer, with temporary maintenance or dose reduction when adverse effects occur [34,35]
So if you take 100 units, less than one actually reaches the bloodstream
An emailed statement from Lars Dalseide, communications director for Gov